Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating infectious bovine meningitis and preparation method thereof

A composition and infectious technology, which is applied in the direction of drug combination, pharmaceutical formula, medical preparations containing active ingredients, etc., can solve the problems that antibiotic treatment is easy to produce drug resistance, the therapeutic effect is not achieved, and the effect is not obvious, etc., to achieve Short course of treatment, no drug residue, no effect of drug resistance

Inactive Publication Date: 2016-02-03
SHANDONG NEW HOPE LIUHE GROUP
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] The effect of western medicine treatment is not obvious, and it is easy to relapse. Antibiotic treatment is easy to produce drug resistance, and the side effects are relatively large
The ideal treatment effect cannot be achieved, and the treatment cost is high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating infectious bovine meningitis and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] Embodiment 1 pharmaceutical composition 1

[0067] The embodiment of the present invention provides a pharmaceutical composition for treating bovine contagious meningitis, which is made of the following raw materials in parts by weight: 9 parts by weight of golden rod, 12 parts by weight of stone flower, 13 parts by weight of gourd tea, glutinous rice 11 parts by weight of roots, 28 parts by weight of Polygonum multiflorum, 17 parts by weight of Zhuru, 5 parts by weight of golden earrings, 14 parts by weight of mahogany, 13 parts by weight of yellow horn, 7 parts by weight of fork boil medicine, 6 parts by weight of fleas, saber 16 parts by weight, 14 parts by weight of silkworm, 28 parts by weight of Gastrodia elata, 4 parts by weight of scorpion, 12 parts by weight of aconite, 21 parts by weight of Uncaria, 18 parts by weight of Fangfeng, 12 parts by weight of Andrographis paniculata, 7 parts by weight of saxifrage, pine needles 17 parts by weight, 16 parts by weight ...

Embodiment 2

[0072] Embodiment 2 pharmaceutical composition 2

[0073] The embodiment of the present invention provides a pharmaceutical composition for treating bovine contagious meningitis, which is made of the following raw materials in parts by weight: 9 parts by weight of golden rod, 12 parts by weight of stone flower, 13 parts by weight of gourd tea, glutinous rice 11 parts by weight of roots, 28 parts by weight of Polygonum multiflorum, 17 parts by weight of Zhuru, 5 parts by weight of golden earrings, 14 parts by weight of mahogany, 13 parts by weight of yellow horn, 7 parts by weight of fork boil medicine, 6 parts by weight of fleas, saber 16 parts by weight, 14 parts by weight of silkworm, 28 parts by weight of Gastrodia elata, 4 parts by weight of scorpion, 12 parts by weight of aconite, 21 parts by weight of Uncaria, 18 parts by weight of Fangfeng, 12 parts by weight of Andrographis paniculata, 7 parts by weight of saxifrage, pine needles 17 parts by weight, 16 parts by weight ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Volume average particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating infectious bovine meningitis and a preparation method thereof. The pharmaceutical composition comprises the following raw medicines: sericeous cinquefoil root, cave flower, tickclover, glutinous rice rhizome and root, fleece-flower root, bamboo shavings, asarum insigne, calyxshaped carrierea seed, cornu procaprae gutturosae, cupleaf passionflower herb, manyleaf paris rhizome, solen, stiff silkworm, rhizoma gastrodiae, scorpion, monkshood, hooked uncaria, radix sileris, common andrographis herb, saxifrage, pine needle, roughhaired holly root, bidens biternata, veronicastrum herb, fortune silene herb with root, pyrola, homalomena rhizoma, roxburgh rose, purple bergenia herb and licorice. The pharmaceutical composition has the beneficial effects that the pharmaceutical composition has main effects of reinforcing real yin, expelling wind and relieving convulsion as well as removing residual poison, has auxiliary effects of regulating the middle warmer and nourishing the stomach, has the advantages of capability of regulating yin, yang, qi and blood, short course of treatment, better effect, small toxic or side effect, low cost and low residue level when being used for treating infectious bovine meningitis, can enhance the bovine immunity and disease resistance, and is green and pollution-free. Moreover, the pharmaceutical composition belongs to a traditional Chinese medicine preparation and is free of drug resistance and drug residue.

Description

technical field [0001] The invention relates to the field of veterinary medicine, in particular to a pharmaceutical composition for treating bovine infectious meningitis and a preparation method thereof. Background technique [0002] Bovine infectious meningoencephalitis, also known as bovine infectious thromboembolic meningoencephalitis (Bovine infectious thromboembolic meningoencephalitis), is an acute septic infectious disease of cattle caused by Haemophilus sleeping. There are many clinical disease types, among which meningoencephalitis, pneumonia, arthritis, respiratory tract infection and reproductive tract diseases are more common. The disease was first discovered in Colorado, USA. It was first described by Griner et al. in 1956. It was later confirmed in Canada, the United Kingdom, West Germany, Switzerland, Italy and some countries in Oceania. After 1977, it was widely prevalent in Japan. [0003] The pathogen Haemophilus somnus (Hemophilusso-mnus) is Gram-negati...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/899A61P9/10A61P25/00A61P31/04A61K35/32A61K35/618A61K35/64
Inventor 黄河李鑫
Owner SHANDONG NEW HOPE LIUHE GROUP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products